Comment on “The Effects of Thyroid Hormone Levels on Patent Ductus Arteriosus Closure in Newborns”
PDF
Cite
Share
Request
Letter to the Editor
VOLUME: 38 ISSUE: 4
P: 296 - 296
December 2023

Comment on “The Effects of Thyroid Hormone Levels on Patent Ductus Arteriosus Closure in Newborns”

Medeni Med J 2023;38(4):296-296
1. University of Baghdad, Al-Kindy College of Medicine, Department of Pediatrics, Baghdad, Iraq
No information available.
No information available
Received Date: 28.10.2023
Accepted Date: 28.11.2023
Publish Date: 26.12.2023
PDF
Cite
Share
Request

Dear Editor,

We read an interesting article by Kaya et al.1 on the influences of thyroid hormone levels on the closure of patent ductus arteriosus (PDA) in Turkish newborns. Kaya et al.1 found that mode of delivery, birth weight, and gestational week were the same between the surgical and medical treatment groups (p>0.05). However, free thyroxine levels were significantly lower in the medical treatment group than in the surgical treatment group (p=0.01). As a result, Kaya et al.1 hypothesized that thyroid hormone levels might contribute to the closure of hemodynamically significant PDA. In addition to the few study limitations mentioned by Kaya et al1, we present the following points. The assessment of thyroid gland health status in children is determined by measuring and interpreting thyroid hormone profiles (THP). Because these profiles are controlled by various factors such as age, gender, ethnicity, dietary iodine intake, and socioeconomic standards2, numerous neonatal population-specific THPs have been created3,4. Turkey interestingly set neonatal THP in 2017 for clinical practice and research5. In the study methodology, Kaya et al.1 didn’t address regretfully which neonatal THPs were used to assess thyroid gland function. This methodological limitation may further erode the accuracy of the study results introduced by Kaya et al.1.

Keywords:
Thyroid hormone levels, patent ductus arteriosus, newborns